Podcast: Play in new window | Download (Duration: 57:55 — 46.9MB) | Embed
Subscribe: Apple Podcasts | RSS
If you had a chance to listen to our very first interview on The Cannabis Reporter Radio Show, Cannabis for Canines Episode I, you’ll recall listening to NY State Assemblyman and veterinarian Dr. Stephen Katz talk about hemp-derived CBD medication for canines.
Last week, Chef Payton Curry spoke with me about edibles, and challenges new patients have getting the dosage right. Since edible medicine is absorbed through digestion, it can take up to an hour to feel the full effect. As he explained, those who aren’t familiar with the delay may think it’s not working and take more… If the medication is high in THC, that can lead to a rather intense euphoric experience, which may be a good thing for those who like the euphoria. But for those who don’t enjoy getting high – or for those who need to function during the day – it can be an uncomfortable problem.
In case you’re wondering what delayed effect of edible medicinals for humans has to do with veterinary formulas for dogs, there is a correlation.
In today’s interview, Dr. Katz has returned for a follow up interview and brought his scientific A-Team, Tony Alfiere, a self-educated scientist, and Dr. Jim Sharkey, who are currently working with Dr. Katz to develop the next generation of Therabis – therapeutic cannabis for canines. They are using new medical accelerant technology invented by Alfiere to expedite absorption and delivery of THC in edibles and elixers, which solves the problem of delayed effectiveness common in edibles. Dr. Jim Sharkey is the Chief Science Officer at Therabis working with Alfiere to apply that technology to therapeutic CBD formulas for dogs and cats.
